Network origin in Karen Lauberg Lauritsen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 55 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Karen Lauberg Lauritsen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| STORA ENSO OYJ | Containers/Packaging | Director of Finance/CFO Corporate Officer/Principal | |
| EQUINOR ASA | Integrated Oil | Director/Board Member Chief Executive Officer | |
| SMITH & NEPHEW PLC | Medical Specialties | Director/Board Member Public Communications Contact | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | President Director/Board Member | |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| DANSKE BANK A/S | Major Banks | Director/Board Member Director/Board Member President | |
| AP MOLLER MAERSK | Marine Shipping | Corporate Officer/Principal Director of Finance/CFO | |
| COLOPLAST A/S | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| KØBENHAVNS LUFTHAVNE A/S | Other Transportation | Chairman | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Director/Board Member Chairman | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman President Chief Executive Officer Public Communications Contact Director/Board Member Chief Executive Officer Chief Executive Officer | |
LEGO A/S
 LEGO A/S Recreational ProductsConsumer Durables LEGO A/S manufactures and markets play materials and toys. The firm offers preschool products, such as loose bricks, play themes, and educational toys for kindergarten toddlers, schoolchildren and teenagers. The company was founded by Ole Kirk Kristiansen in 1932 and is headquartered in Billund, Denmark. | Recreational Products | Director/Board Member Corporate Officer/Principal | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member | |
DADES A/S
 DADES A/S Real Estate DevelopmentFinance DADES A/S provides real estate investment services. It owns and operates shopping centers, office buildings, and residential properties. The company was founded by Ejnar Danielsen in 1937 and is headquartered in Kongens Lyngby, Denmark. | Real Estate Development | Director/Board Member Director/Board Member Chairman | |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Director/Board Member Director/Board Member | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
| University of Aarhus | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree Undergraduate Degree | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Undergraduate Degree Doctorate Degree | |
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of Copenhagen | College/University | Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | President President | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Novo Nordisk North America, Inc. | Director of Finance/CFO Corporate Officer/Principal | ||
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chairman Chief Executive Officer | |
| Danmark-Amerika Fondet | Chairman Director/Board Member | ||
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NNIT A/S | Information Technology Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Astra Zeneca Holding France SAS
 Astra Zeneca Holding France SAS Pharmaceuticals: MajorHealth Technology Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | President | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chairman Director/Board Member |
Statistics
International
| Denmark | 27 |
| United States | 8 |
| United Kingdom | 5 |
| Sweden | 5 |
| Switzerland | 4 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 9 |
| Finance | 6 |
| Process Industries | 3 |
| Transportation | 3 |
Operational
| Director/Board Member | 276 |
| Chairman | 114 |
| Corporate Officer/Principal | 104 |
| Independent Dir/Board Member | 85 |
| Chief Executive Officer | 51 |
Most connected contacts
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Göran Albert Ando | 44 |
| Sten Scheibye | 31 |
| Jeppe Fonager Christiansen | 26 |
| Thomas Paul Koestler | 26 |
| Sylvie Grégoire | 25 |
| Helge Lund | 24 |
| Lise Kingo | 23 |
| Jan Ulf Sigvar J. Johansson | 23 |
| Pamela Kirby | 22 |
| Terje Kalland | 20 |
| Hannu Ragnvald Ryöppönen | 20 |
| Per Toft Valstorp | 19 |
| Mary Szela | 19 |
| Kurt Anker Nielsen | 18 |
- Stock Market
- Insiders
- Karen Lauberg Lauritsen
- Company connections
